Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 May 12;17(5):e83952.
doi: 10.7759/cureus.83952. eCollection 2025 May.

Anesthetic Management of Atypical Toxic Epidermal Necrolysis in a Six-Month-Old Patient Undergoing Burn Surgery: A Case Report

Affiliations
Case Reports

Anesthetic Management of Atypical Toxic Epidermal Necrolysis in a Six-Month-Old Patient Undergoing Burn Surgery: A Case Report

Cassidy Chau et al. Cureus. .

Abstract

Toxic epidermal necrolysis (TEN) is a rare, life-threatening skin condition that involves widespread skin detachment and mucous membrane damage. We present a case of a six-month-old male with atypical TEN transferred from an outside hospital in Mexico to our facility. The patient had widespread full-thickness necrotic wounds but no bullae or sloughing. Since the diagnosis was unclear at the time, it posed a significant challenge to make an appropriate anesthetic plan given the need for prolonged intubation after extensive burn debridement and grafting surgery. This case report highlights the importance of perioperative assessment, induction strategy, airway management, resuscitation, and pain control in an atypical TEN patient.

Keywords: burn resuscitation; fiberoptic intubation; ketamine and dexmedetomidine; pediatric burn pain management; toxic epidermal necrolysis (ten).

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Images of the patient's full-thickness necrotic wounds
The authors discussed and obtained consent from the parent(s) to use the patient's images/information for the purpose of education and research.
Figure 2
Figure 2. Fiberoptic examination of the patient's nasopharynx
Fiberoptic examination demonstrating (A) normal right nasal septum with spotty erythema and (B) mild glottic swelling. Notably, no friability or mucosal bleeding was observed.

Similar articles

References

    1. Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults. Hsu DY, Brieva J, Silverberg NB, Silverberg JI. J Invest Dermatol. 2016;136:1387–1397. - PubMed
    1. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases. Pejčić AV. Int J Dermatol. 2021;60:12–24. - PubMed
    1. Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Villada G, Roujeau JC, Clérici T, Bourgault I, Revuz J. Arch Dermatol. 1992;128:50–53. - PubMed
    1. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. French LE. Allergol Int. 2006;55:9–16. - PubMed
    1. Toxic epidermal necrolysis in early infancy. Scully MC, Frieden IJ. J Am Acad Dermatol. 1992;27:340–344. - PubMed

Publication types

LinkOut - more resources